Profil
Kevin Sheil is currently working as a Consultant at First Berlin Equity Research GmbH.
He has previously worked as a Non-Executive Director at AfriAg Global Plc, Director at Apollon Formularies Plc, General Manager-Equity Fund at Trium Capital Managers Ltd., and Head-Corporate Development & Strategy at 80 Mile Plc.
Postes actifs de Kevin Sheil
| Sociétés | Poste | Début |
|---|---|---|
First Berlin Equity Research GmbH
First Berlin Equity Research GmbH Investment ManagersFinance Provides investment research | Analyst-Equity | 01/09/2024 |
Anciens postes connus de Kevin Sheil
| Sociétés | Poste | Fin |
|---|---|---|
| 80 MILE PLC | Public Communications Contact | 01/02/2024 |
Apollon Formularies Plc
Apollon Formularies Plc Pharmaceuticals: OtherHealth Technology Produces medical cannabis | Directeur/Membre du Conseil | 27/01/2022 |
Trium Capital Managers Ltd.
Trium Capital Managers Ltd. Investment Banks/BrokersFinance Engages in the purchase, sale, and brokerage of securities | Corporate Officer/Principal | - |
| AFRIAG GLOBAL PLC | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AfriAg Global Plc
AfriAg Global Plc Medical SpecialtiesHealth Technology Provides investment services | Health Technology |
First Berlin Equity Research GmbH
First Berlin Equity Research GmbH Investment ManagersFinance Provides investment research | Finance |
80 Mile Plc
80 Mile Plc Other Metals/MineralsNon-Energy Minerals Explores for copper, nickel and zinc | Non-Energy Minerals |
Trium Capital Managers Ltd.
Trium Capital Managers Ltd. Investment Banks/BrokersFinance Engages in the purchase, sale, and brokerage of securities | Finance |
Apollon Formularies Plc
Apollon Formularies Plc Pharmaceuticals: OtherHealth Technology Produces medical cannabis | Health Technology |
















